MEDICUS PHARMA LTD (MDCX) Stock Earnings & Estimates
USA - NASDAQ:MDCX - CA58471K2020 - Common Stock
2.51 USD
-0.12 (-4.56%)
2.4308 USD
-0.08 (-3.16%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 208.95% | N/A 127.92% | N/A 90.38% | N/A 62.43% | |||||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -31.1K | -91.9K -195.50% | -53.4K 41.89% | -58.6K -9.74% | -131.4K -124.23% | -88.1K 32.95% | -141.7K -60.84% | -978.4K -590.47% | -2.658M -171.70% | -11.181M -320.60% | N/A -72.58% | N/A -39.00% | N/A -26.65% | N/A 74.11% | N/A 843.07% | N/A 236.69% | N/A 120.90% | N/A 73.44% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -2.01 20.05% | N/A 39.49% | N/A 28.57% | N/A 4.12% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.24 71.06% | -0.13 26.33% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -4.517M -50.27% | -3.415M -7.02% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.42 38.60% | -0.26 | -0.16 | -60.43% |
| Q1 2025 Q2Q % growth | -0.42 -41.89% | -0.24 | -0.18 | -76.47% |
| Q4 2024 Q2Q % growth | -0.18 63.27% | -0.30 | 0.12 | 39.15% |
| Q3 2024 Q2Q % growth | -0.85 | -0.39 | -0.46 | -118.27% |
| Q2 2024 Q2Q % growth | -0.68 | -0.22 | -0.46 | -204.81% |
| Q1 2024 Q2Q % growth | -0.30 | -0.37 | 0.07 | 19.39% |
| Q4 2023 Q2Q % growth | -0.49 | -0.43 | -0.06 | -14.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -26.32% | -6.73% | -66.43% |
| Revenue | N/A | N/A | N/A | N/A |